Hawkins (NASDAQ:HWKN) Upgraded at Zacks Research

Key Points

• Hawkins (NASDAQ:HWKN) has been upgraded to a "strong-buy" rating by Zacks Research, reflecting improved outlook for the company's stock.
• BWS Financial has increased their price target for Hawkins from $160 to $200, demonstrating analyst confidence in the stock's performance.
• Hawkins reported earnings of $1.40 per share, exceeding expectations, with revenues reaching $293.27 million for the last quarter.

Hawkins (NASDAQ:HWKN - Get Free Report) was upgraded by investment analysts at Zacks Research to a "strong-buy" rating in a research report issued on Tuesday,Zacks.com reports.

Other equities research analysts also recently issued reports about the company. BWS Financial increased their price objective on Hawkins from $160.00 to $200.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Raymond James Financial assumed coverage on Hawkins in a research report on Thursday, July 24th. They issued a "market perform" rating on the stock. Finally, Wall Street Zen lowered Hawkins from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Hawkins currently has an average rating of "Moderate Buy" and a consensus target price of $162.50.

Hawkins Trading Down 3.6%

Shares of Hawkins stock opened at $172.29 on Tuesday. The company has a quick ratio of 1.45, a current ratio of 2.31 and a debt-to-equity ratio of 0.59. The firm has a market cap of $3.60 billion, a price-to-earnings ratio of 42.44, a price-to-earnings-growth ratio of 2.56 and a beta of 0.81. The business has a fifty day simple moving average of $153.74 and a 200-day simple moving average of $128.31. Hawkins has a fifty-two week low of $98.30 and a fifty-two week high of $185.50.

Hawkins (NASDAQ:HWKN - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.07. The business had revenue of $293.27 million during the quarter, compared to analyst estimates of $278.76 million. Hawkins had a return on equity of 18.35% and a net margin of 8.37%. On average, equities analysts forecast that Hawkins will post 4 EPS for the current fiscal year.

Hedge Funds Weigh In On Hawkins

Several institutional investors have recently bought and sold shares of the business. Brooklyn Investment Group increased its holdings in Hawkins by 533.3% in the first quarter. Brooklyn Investment Group now owns 266 shares of the specialty chemicals company's stock valued at $28,000 after purchasing an additional 224 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its holdings in Hawkins by 118.8% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 280 shares of the specialty chemicals company's stock valued at $30,000 after purchasing an additional 152 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in Hawkins in the second quarter valued at about $31,000. Vermillion Wealth Management Inc. bought a new stake in Hawkins in the fourth quarter valued at about $34,000. Finally, Caitong International Asset Management Co. Ltd bought a new stake in Hawkins in the first quarter valued at about $42,000. Institutional investors own 69.71% of the company's stock.

About Hawkins

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.